Press release
Nanotechnology-Enabled Drug Delivery Devices Market to hit US$ 179.12 billion by 2033 | Transforming Future of Drug Delivery Till 2033
Nanotechnology-Enabled Drug Delivery Devices
DataM Intelligence has released its latest report on the "Nanotechnology-Enabled Drug Delivery Devices Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/nanotechnology-enabled-drug-delivery-devices-market?kb
Latest M&A
The nanotechnology drug delivery devices market has seen moderate M&A activity in 2025, with major pharmaceutical companies like AbbVie, Pfizer, and Novartis acquiring or partnering with specialized nanotech firms to expand targeted drug delivery capabilities.
Pharmaceutical giants invest in nanocarrier platforms for oncology, neurology, and infectious diseases to enhance drug solubility, bioavailability, and targeted therapeutic effects.
Forecast Growth Projected:
The Global Nanotechnology-Enabled Drug Delivery Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Nanotechnology-Enabled Drug Delivery Devices Market:
Merck & Co., Inc, Pfizer Inc, Novartis AG, Sanofi S.A., Gilead Sciences, Inc, and GSK among others.
Segment Covered in the Nanotechnology-Enabled Drug Delivery Devices Market:
By Product Type:
✅ Nanoparticles - Dominated the market with 32.8% share in 2024
✅ Liposomes - Accounted for 25.6% share, widely used in drug delivery systems
✅ Nanocrystals - Held around 18.4% share, driven by improved bioavailability applications
✅ Micelles - Captured 12.3% share, increasingly adopted in targeted therapies
✅ Nanotubes - Represented 6.1% share, with growing interest in cancer treatment research
✅ Others - Contributed 4.8% share
By Application:
✅ Oncology - Led the segment with 37.2% share in 2024 due to rising cancer prevalence
✅ Neurology - Accounted for 21.5% share, supported by nanocarrier use in brain-targeted delivery
✅ Cardiovascular/Physiology - Held 14.6% share, driven by controlled release formulations
✅ Anti-inflammatory/Immunology - Captured 12.9% share
✅ Anti-infective - Represented 8.3% share
✅ Others - Accounted for 5.5% share
By End-User:
✅ Pharmaceutical and Biotechnology Companies - Dominated with 41.7% share in 2024
✅ Hospitals and Clinics - Accounted for 28.9% share, due to growing nanomedicine use in therapies
✅ Research Institutes and Laboratories - Held 21.4% share, fueled by ongoing nanotech R&D
✅ Others - Contributed 8.0% share
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/nanotechnology-enabled-drug-delivery-devices-market?kb
Regional Analysis:
The global Nanotechnology-Enabled Drug Delivery Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Nanotechnology-Enabled Drug Delivery Devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Nanotechnology-Enabled Drug Delivery Devices manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Nanotechnology-Enabled Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=nanotechnology-enabled-drug-delivery-devices-market?kb
People Also Ask
Q1: How large is the Nanotechnology-Enabled Drug Delivery Devices Market?
Ans: The Nanotechnology-Enabled Drug Delivery Devices Market size was valued at US$ 54.22 billion in 2024 and is projected to grow to US$ 179.12 billion by 2033.
Q2: How quickly is the Nanotechnology-Enabled Drug Delivery Devices Market expanding?
Ans: The Nanotechnology-Enabled Drug Delivery Devices Market is forecasted to grow at a CAGR of 12.6% between 2025 and 2033, Imapct strong Annual Growth momentum
Q3: Which regions are dominating the Nanotechnology-Enabled Drug Delivery Devices Market and which are fastest-growing?
Ans: North America dominating the Nanotechnology-Enabled Drug Delivery Devices market.
Recent Product Launches & Innovations
New nanocarrier drug formulations approved or launched in 2025 target oncology, cardiovascular, and neurodegenerative diseases, offering reduced side effects and improved efficacy.
Advances in micro-robotics and AI are being integrated with nanotechnology drug delivery systems to enhance precision dosing and overcome biological barriers.
Companies are advancing smart nanoparticle delivery systems capable of multi-drug release in programmable sequences tailored to patient-specific needs.
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/nanotechnology-enabled-drug-delivery-devices-market?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Linkedin: https://www.linkedin.com/company/datam-intelligence/
Twitter: https://x.com/DataM_Research
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nanotechnology-Enabled Drug Delivery Devices Market to hit US$ 179.12 billion by 2033 | Transforming Future of Drug Delivery Till 2033 here
News-ID: 4263355 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
High Protein Snacks Market to Witness Exceptional Growth Amid Rising Health Cons …
High Protein Snacks Market to Witness Exceptional Growth Amid Rising Health Consciousness and Demand for Convenient Nutrition | DataM Intelligence
According to DataM Intelligence, the global High Protein Snacks Market is projected to grow from USD 27.9 billion in 2024 to USD 65 billion by 2032, exhibiting a promising compound annual growth rate (CAGR) of 60% over the forecast period from 2025 to 2032. The rising consumer focus on health, fitness,…
France Probiotic Drinks Market: Innovation in Flavor & Packaging Trends in 2025 …
Market Size and Overview:
The France probiotic drinks market recorded a value of US$ 1,125.26 million in 2024 and is expected to reach a value of US$ 1,476.29 million in 2028, growing at a CAGR of 7.16% during the forecast period (2025-2028).
According to DataM Intelligence Comprehensive Report has released its latest report on the "France Probiotic Drinks Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive…
United States Genetic Testing Market to Reach USD 54.21 Billion by 2033, Driven …
The Global Genetic Testing Market size reached US$14.72 billion in 2024 and is expected to reach US$54.21 billion by 2033, growing at a CAGR of 15.4% during the forecast period 2025-2033, according to the DataM Intelligence report.
This growth is driven by rising demand for personalized medicine, early disease detection, and advances in genomic technologies that enhance testing accuracy and speed. Expanding applications in oncology, rare diseases, and pharmacogenomics further propel…
US Peripheral IV Catheters Market Growth Forecast 2023-2030: Market Set to Reach …
The Global Peripheral IV Catheters Market was valued at US$ 5.2 billion in 2022 and is projected to reach US$ 9.1 billion by 2030, registering a CAGR of 7.4% during 2023-2030. Market growth is driven by the rising prevalence of chronic and infectious diseases, increasing hospital admissions, and growing demand for reliable vascular access devices in healthcare settings.
Innovations in catheter design, including safety-engineered and antimicrobial-coated products, are improving patient safety…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
